STRS Ohio
AVLN icon

STRS Ohio’s Avalyn Pharma AVLN Stock Holding History

STRS Ohio’s Portfolio AVLN Stock Details AVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$88.3K Sell
3,100
-300
-9% -$9.7K ﹤0.01% 1914
2026
Q2 		$112K Buy
+3,400
New +$98.1K ﹤0.01% 1838

Other funds holding AVLN

Andera Partners
Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Lewis Asset Management
Lewis Asset Management Lafayette, California $294M AUM 25.62% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Manchester Capital Management
Manchester Capital Management Manchester, Vermont $736M AUM 20.83% 1-Year Est. Return

STRS Ohio's AVLN Position: Q3 2026 in Review

STRS Ohio reduced its Avalyn Pharma (AVLN) stake by 8.8% in Q3 2026, selling an estimated $9.7K and leaving 3,100 shares worth $88.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1914.

STRS Ohio first reported a position in AVLN in Q2 2026 and has held it in 2 quarters since. The position peaked at $112K in Q2 2026. 23 funds tracked by Wall St. Rank hold AVLN as of Q3 2026.

  • STRS Ohio held 3,100 shares of Avalyn Pharma worth $88.3K as of Q3 2026.
  • STRS Ohio sold 300 Avalyn Pharma shares in Q3 2026, an estimated $9.7K.
  • Avalyn Pharma made up ﹤0.01% of STRS Ohio's portfolio in Q3 2026, its #1914 holding.
  • STRS Ohio first reported a position in Avalyn Pharma in Q2 2026 and has held it in 2 quarters since.
  • STRS Ohio's Avalyn Pharma position peaked at $112K in Q2 2026.
  • 23 funds tracked by Wall St. Rank held Avalyn Pharma as of Q3 2026.

Based on STRS Ohio's 13F filing for Q3 2026, filed 30 Oct 2026.